Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Courts cannot be expected to usurp powers of experts in academic matters: HC junks plea challenging NEET 2022 answer key

Farhat Nasim15 Oct 2022 12:51 PM IST

New Delhi: Observing that unless the candidate demonstrates that the key answers are patently wrong on the face of it, the courts cannot enter into...

Referring patient to higher centre is not negligence: NCDRC absolves Delhi Hospital, ENT Surgeon

Farhat Nasim5 Oct 2022 11:30 AM IST

Jaipur: Holding that referring a patient to higher center is not negligence of treating doctor, the National Consumer Disputes Redressal Commission...

Kerala HC directs Health Ministry, DoP to reply on unaffordability of patented cancer drug Ribociclib

Farhat Nasim2 Oct 2022 4:00 PM IST

Thiruvananthapuram: The Kerala High Court has directed the Department of Pharmaceuticals (DoP) and a competent officer of Union Health Ministry to...

Fake drug menace in Baddi, over 300 Telma-H tablet of Glenmark seized

Farhat Nasim26 Sept 2022 6:17 PM IST

Solan: Busting a fake drug racket, the officials of the Drugs Control Administration (DCA) have seized counterfeit BP drug, Telma-H tablet...

6 months jail to Singh brothers In Daiichi-Fortis Case, SC refuses to lift stay on Fortis-IHH open offer

Farhat Nasim22 Sept 2022 2:41 PM IST

New Delhi: The former promoters of Fortis Healthcare, Malvinder Singh and Shivinder Singh (Singh brothers) will now have to serve a jail term of 6...

Meet 52 richest Indians in Pharma Healthcare domain

Farhat Nasim21 Sept 2022 7:33 PM IST

New Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun...

Govt Invites Pharma Firms to Submit Data for Ceiling Price Review

DoP should be under Ministry of Health not Chemicals and Fertilizers: Parliamentary Panel

Farhat Nasim20 Sept 2022 5:43 PM IST

New Delhi: In order to resolve some of the major challenges being faced by the medical device manufacturers and to achieve better coordination, the...

Parliamentary Panel recommends separate legislation, National Commission On Medical Devices

Farhat Nasim15 Sept 2022 5:36 PM IST

New Delhi: The Department-Related Parliamentary Standing Committee (DRPSC) on Health and Family Welfare has recommended a separate legislation for the...

Gujarat HC upholds criminal prosecution of 2 orthopaedic surgeons, says patient consent doesn't cover negligence

Farhat Nasim15 Sept 2022 5:02 PM IST

Ahmedabad: Upholding the criminal prosecution of 2 orthopaedic surgeons, the Gujarat High Court observed that a patient's consent for surgery cannot...

Union Health Ministry releases NLEM 2022, 34 drugs added, 26 removed

Farhat Nasim13 Sept 2022 5:56 PM IST

New Delhi: The Union Health Ministry on Tuesday released the National List of Essential Medicines (NLEM) 2022 . The new list comprises of 384 drugs...

GSK Nucala application for COPD accepted for review in China

GSK notice to Akums, associate on alleged trademark infringement on its Ranitidine brand Zinetac

Farhat Nasim8 Sept 2022 6:23 PM IST

New Delhi: Locking horns over alleged trademark infringement of 'Zinetac', Glaxo Smith Kline (GSK) Pharmaceuticals has issued cease and desist notices...

Indian Pharma Market sees 12.1 percent growth in August: AIOCD-AWACS Report

Farhat Nasim7 Sept 2022 5:53 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) saw significant growth of 12.1 percent in value and 4.8 percent in volume, in the month of August,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok